Amarin Corp ADR (AMRN)

Amarin Corp ADR [AMRN] President and CEO makes an insider purchase of 14426 shares worth 15724.0. – Knox Daily - Knox Daily

Knox Daily

Amarin Corp ADR (AMRN) expanding its growth trajectory ahead – Sete News - SETE News

SETE News

Amarin Corp ADR [AMRN] Investment Guide: What You Need to Know – Knox Daily - Knox Daily

Knox Daily

Amarin Corp ADR (AMRN) stock on the rise: An overview – US Post News - US Post News

US Post News

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

GlobeNewswire Inc.

Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus

Zacks Investment Research

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall

Zacks Investment Research

Does Amarin Corp ADR (AMRN) offer a good opportunity for investors? – Sete News - SETE News

SETE News

Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates

Zacks Investment Research

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript

The Motley Fool

Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short

Zacks Investment Research

A year in review: Amarin Corp ADR (AMRN)'s performance in the last year – US Post News - US Post News

US Post News

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

GlobeNewswire Inc.

Amarin Announces Results of Annual General Meeting of Shareholders

GlobeNewswire Inc.

Amarin Corp ADR's latest rating changes from various analysts – Knox Daily - Knox Daily

Knox Daily

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

GlobeNewswire Inc.

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

GlobeNewswire Inc.

Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe

Zacks Investment Research

Why Amarin Stock Was Rocketing Higher on Wednesday

The Motley Fool

Why Amarin Stock Was Rocketing Higher on Wednesday - sharewise

sharewise

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

GlobeNewswire Inc.

Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates

Zacks Investment Research

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

The Motley Fool

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Can Rising Operating Costs Affect Acadia's (ACHC) Q4 Earnings?

Zacks Investment Research

Can Higher Admissions Drive Universal Health (UHS) Q4 Earnings?

Zacks Investment Research

Aquestive (AQST) to Report Q4 Earnings: Here's What to Expect

Zacks Investment Research

Can Low Occupancy Rate Affect Select Medical (SEM) Q4 Earnings?

Zacks Investment Research

Altimmune (ALT) to Report Q4 Earnings: What's in the Cards?

Zacks Investment Research

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024

GlobeNewswire Inc.

5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates

Zacks Investment Research

Amarin Chairman & CEO Issue Letter to Shareholders

GlobeNewswire Inc.

Are Medical Stocks Lagging Amarin (AMRN) This Year?

Zacks Investment Research

Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday

Benzinga

Why Amarin Stock Skyrocketed Today

The Motley Fool

Crude Oil Falls 1%; Amarin Shares Spike Higher

Benzinga

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week

Benzinga

Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024

GlobeNewswire Inc.

Why Is Amicus Therapeutics (FOLD) Up 15% Since Last Earnings Report?

Zacks Investment Research

What Makes Amarin (AMRN) a New Buy Stock

Zacks Investment Research

3 Biotech Stocks to Avoid Like the Plague - InvestorPlace

InvestorPlace

Amarin Fish-Oil Heart Drug Good News Is Already Priced In Stock - Bloomberg

Bloomberg

Amarin Fish Oil Capsule Vascepa Gets ICER Value Stamp - Bloomberg

Bloomberg

Amarin (AMRN) Surges on Booming Heart Pill Sales - Bloomberg

Bloomberg

Amarin (AMRN) Fish-Oil Heart Medicine Win Is Rarest Drug Success - Bloomberg

Bloomberg